References
- Institute for Health Metrics and Evaluation (IHME) . Global Burden of Disease Study 2019 (GBD 2019) results. (2020). http://ghdx.healthdata.org/gbd-results-tool
- Centers for Disease Control and Prevention (CDC) . Cost statistics: the cost of arthritis in US adults.. Centers for Disease Control and Prevention, Atlanta (2020). www.cdc.gov/arthritis/data_statistics/cost.htm
- Gill LL . CBD goes mainstream. Consum. Rep. (2019). www.consumerreports.org/cbd/cbd-goes-mainstream/
- Arthritis Foundation . Patients tell us about CBD use. (2019). http://blog.arthritis.org/news/patients-tell-us-cbd-use/
- Blake A , WanBA , MalekLet al. A selective review of medical cannabis in cancer pain management. Ann. Palliat. Med.6(Suppl. 2), S215–S222 (2017).
- Russo EB . Cannabinoids in the management of difficult to treat pain. Ther. Clin. Risk Manag.4(1), 245–259 (2008).
- Mondello E , QuattroneD , CardiaLet al. Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain. J. Pain Res.11, 1761–1767 (2018).
- Nagarkatti P , PandeyR , RiederSA , HegdeVL , NagarkattiM. Cannabinoids as novel anti-inflammatory drugs. Future Med. Chem.1(7), 1333–1349 (2009).
- Atalay S , Jarocka-karpowiczI , SkrzydlewskasE. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants.9(1), 21 (2020).
- Kuhathasan N , DufortA , MacKillopJ , GottschalkR , MinuzziL , FreyBN. The use of cannabinoids for sleep: a critical review on clinical trials. Exp. Clin. Psychopharmacol.27(4), 383–401 (2019).
- Russo EB , GuyGW , RobsonPJ. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of sativexρ, a cannabis-based medicine. Chem. Biodivers.4(8), 1729–1743 (2007).
- Blessing EM , SteenkampMM , ManzanaresJ , MarmarCR. Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics12(4), 825–836 (2015).
- Aviello G , RomanoB , IzzoAA. Cannabinoids and gastrointestinal motility: animal and human studies. Eur. Rev. Med. Pharmacol. Sci.12(Suppl. 1), 81–93 (2008).
- Di Marzo V , PiscitelliF. Gut feelings about the endocannabinoid system. Neurogastroenterol. Motil.23(5), 391–398 (2011).
- Parker LA , RockEM , LimebeerCL. Regulation of nausea and vomiting by cannabinoids. Br. J. Pharmacol.163(7), 1411–1422 (2011).
- Belardo C , IannottaM , BoccellaSet al. Oral cannabidiol prevents allodynia and neurological dysfunctions in a mouse model of mild traumatic brain injury. Front. Pharmacol.10, 352 (2019).
- Kisková T , MungenastF , SuvákováM , JägerW , ThalhammerT. Future aspects for cannabinoids in breast cancer therapy. Int. J. Mol. Sci.20(7), 1673 (2019).
- O’Brien M , McDougallJJ. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids. Curr. Opin. Pharmacol.40, 104–109 (2018).
- Fitzcharles MA , BaerwaldC , AblinJ , HäuserW. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): a systematic review of randomized controlled trials. Schmerz30(1), 47–61 (2016).
- Langford RM , MaresJ , NovotnaAet al. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. J. Neurol.260(4), 984–997 (2013).
- International Association for the Study of Pain . IASP position statement on the use of cannabinoids to treat pain. (2021). www.iasp-pain.org/PublicationsNews/NewsDetail.aspx?ItemNumber=11145&navItemNumber=643
- Pratt M , StevensA , ThukuMet al. Benefits and harms of medical cannabis: a scoping review of systematic reviews. Syst. Rev.8(1), 320 (2019).
- Bakshi C , BarrettAM. Impact of recreational and medicinal marijuana on surgical patients: a review. Am. J. Surg.217(4), 783–786 (2019).
- Huson HB , GranadosTM , RaskoY. Surgical considerations of marijuana use in elective procedures. Heliyon4(9), e00779 (2018).
- Rajamäki TJ , PuolakkaPA , HietaharjuA , MoilanenT , JämsenE. Use of prescription analgesic drugs before and after hip or knee replacement in patients with osteoarthritis. BMC Musculoskelet. Disord.20(1), 427 (2019).
- Deckey DG , LaraNJ , GulbrandsenMT , HassebrockJD , SpangehlMJ , BinghamJS. Prevalence of cannabinoid use in patients with hip and knee osteoarthritis. J.AAOS Glob. Res. Rev.5(2), e20.00172 (2021).
- Lötsch J , Weyer-MenkhoffI , TegederI. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings. Eur. J. Pain22(3), 471–484 (2018).
- Zou S , KumarU. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int. J. Mol. Sci.19(3), 833 (2018).
- Pertwee RG . The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9-tetrahydrocannabinol, cannabidiol and Δ 9-tetrahydrocannabivarin. Br. J. Pharmacol.153(2), 199–215 (2008).
- Moon AS , SmithW , MullenSet al. Marijuana use and mortality following orthopedic surgical procedures. Subst. Abus.40(3), 378–382 (2019).